Alzheimer’s Disease is a chronic neurodegenerative disease known widely for its primary symptom, a progressively worse dementia that begins with short-term memory loss. As Alzheimer’s advances, other symptoms develop, including linguistic and behavioural issues and loss of bodily functions. Unfortunately, at the moment, there is no known cure for Alzheimer’s. Learn more about this disease at the Alzheimer Society of Canada, an invaluable webpage for resources.

This month in Canada is Alzheimer’s Awareness Month, an ideal time to look at avenues that are being explored for the treatment and prevention of Alzheimer’s. One path that is currently undergoing research is medical cannabis. Below we present links to ongoing research into the therapeutic potential of medical cannabis for Alzheimer’s patients as well as in the prevention of Alzheimer’s.

Medical Cannabis and Alzheimer’s: Current Research

Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention?
Discriminative Properties of Hippocampal Hypoperfusion in Marijuana Users Compared to Healthy Controls: Implications for Marijuana Administration in Alzheimer’s Dementia.
A Molecular Link Between the Active Component of Marijuana and Alzheimer’s Disease Pathology
Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging
The potential therapeutic effects of THC on Alzheimer’s disease.